Lower Dementia Risk Seen With SGLT2is in Seniors 65+ With Mood, Psychotic Disorders
THURSDAY, July 9, 2026 -- Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is associated with a lower risk for dementia in older adults with mood and psychotic disorders, according to a study published online June 30 in JAMA Network Open.
David...
Read more »